Skip to Content

Ezetimibe and Atorvastatin Tablets

Last Updated: May 8, 2018
Status: Current

Products Affected - Description
    • Liptruzet tablet, Merck, 10 mg/ 10 mg, unit of use packages of 90, NDC 66582-0320-54
    • Liptruzet tablet, Merck, 10 mg/ 10 mg, unit of use packages of 30, NDC 66582-0320-30
    • Liptruzet tablet, Merck, 10 mg/ 20 mg, unit of use packages of 90, NDC 66582-0321-54
    • Liptruzet tablet, Merck, 10 mg/ 20 mg, unit of use packages of 30, NDC 66582-0321-30
    • Liptruzet tablet, Merck, 10 mg/ 40 mg, unit of use packages of 90, NDC 66582-0322-54
    • Liptruzet tablet, Merck, 10 mg/ 40 mg, unit of use packages of 30, NDC 66582-0322-30
    • Liptruzet tablet, Merck, 10 mg/ 80 mg, unit of use packages of 90, NDC 66582-0323-54
    • Liptruzet tablet, Merck, 10 mg/ 80 mg, unit of use packages of 30, NDC 66582-0323-30
Reason for the Shortage
    • In January 2014, Merck recalled all Liptruzet lots from wholesalers due to packaging defects in the outer laminate foil pouches.
    • Merck discontinued Liptruzet in June 2016.
Available Products
    • No products are available.

Estimated Resupply Dates

    • Merck discontinued all Liptruzet presentations in June 2015.

Updated

Updated May 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 24, 2014 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide